DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE

DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE was reported 7929 times

DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRABECULOPLASTY 5 0.1282
1 GLAUCOMA SURGERY 22 0.0859
2 TRABECULECTOMY 6 0.0652
3 EYE BURNS 34 0.0577
4 VIRAL UVEITIS 5 0.0515
5 INTRAOCULAR PRESSURE FLUCTUATION 10 0.0508
6 INTRAOCULAR PRESSURE TEST ABNORMAL 32 0.0454
7 RETINAL OCCLUSIVE VASCULITIS 8 0.0357
8 THUNDERCLAP HEADACHE 8 0.0305
9 CORNEAL INFILTRATES 9 0.0287
10 INTRAOCULAR PRESSURE INCREASED 366 0.0286
11 INTRAOCULAR PRESSURE DECREASED 15 0.0285
12 EYELID INJURY 5 0.0284
13 CORNEAL NEOVASCULARISATION 7 0.0283
14 CORNEAL DECOMPENSATION 4 0.0248
15 OPEN ANGLE GLAUCOMA 15 0.0244
16 IRIS HYPERPIGMENTATION 5 0.0240
17 CHOROIDAL DETACHMENT 12 0.0216
18 CORNEAL DEGENERATION 5 0.0207
19 SUPERFICIAL INJURY OF EYE 21 0.0192
20 HYPHAEMA 10 0.0192
21 REACTION TO PRESERVATIVES 15 0.0184
22 CORNEAL OPACITY 25 0.0183
23 PALPABLE PURPURA 5 0.0182
24 PANCREATIC DUCT DILATATION 5 0.0182
25 COLITIS MICROSCOPIC 79 0.0167
26 GROWTH OF EYELASHES 13 0.0164
27 LID SULCUS DEEPENED 6 0.0161
28 EYELID SKIN DRYNESS 19 0.0157
29 PRODUCT DROPPER ISSUE 12 0.0152
30 EYE LASER SURGERY 9 0.0152
31 EYELID MARGIN CRUSTING 44 0.0152
32 EYELID EXFOLIATION 12 0.0152
33 INSTILLATION SITE ERYTHEMA 8 0.0152
34 GLAUCOMA 281 0.0146
35 GASTROINTESTINAL ANGIODYSPLASIA 6 0.0146
36 PERIORBITAL PAIN 12 0.0142
37 EYE INJURY 43 0.0141
38 CORNEAL TRANSPLANT 11 0.0140
39 EYE IRRITATION 799 0.0139
40 OCULAR HYPERAEMIA 648 0.0136
41 THYROXINE DECREASED 8 0.0129
42 EYE INFECTION VIRAL 4 0.0125
43 BLEPHARITIS 49 0.0122
44 INTRAOCULAR LENS IMPLANT 6 0.0121
45 FOREIGN BODY SENSATION IN EYES 76 0.0119
46 HYPOTONY OF EYE 5 0.0119
47 EYE PRURITUS 396 0.0118
48 EYELID IRRITATION 29 0.0115
49 INJURY CORNEAL 6 0.0115
50 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 4 0.0110
51 CORNEAL ABRASION 15 0.0109
52 EYELID PAIN 22 0.0108
53 EYE INFECTION BACTERIAL 6 0.0108
54 CORNEAL DEPOSITS 8 0.0108
55 CHOROIDITIS 4 0.0107
56 SCLERAL HYPERAEMIA 7 0.0103
57 CORNEAL OEDEMA 23 0.0103
58 VITRECTOMY 6 0.0101
59 SPIROMETRY ABNORMAL 6 0.0100
60 EYELIDS PRURITUS 31 0.0099
61 BLEPHARAL PIGMENTATION 5 0.0099
62 EYE DISCHARGE 102 0.0098
63 OCULAR HYPERTENSION 19 0.0098
64 FRACTURE PAIN 5 0.0093
65 ERYTHEMA OF EYELID 50 0.0092
66 ENDOCRINE OPHTHALMOPATHY 8 0.0092
67 CATARACT NUCLEAR 6 0.0090
68 EYE PAIN 492 0.0087
69 OPHTHALMIC HERPES SIMPLEX 5 0.0087
70 OCULAR VASCULAR DISORDER 7 0.0085
71 VITREOUS OPACITIES 7 0.0083
72 TOXIC ANTERIOR SEGMENT SYNDROME 9 0.0082
73 EYELID RASH 8 0.0082
74 CORNEAL PERFORATION 5 0.0079
75 MITRAL VALVE CALCIFICATION 5 0.0078
76 CORNEAL EROSION 4 0.0074
77 FOREIGN BODY IN EYE 7 0.0073
78 PRODUCT CONTAINER ISSUE 61 0.0071
79 EYE ALLERGY 11 0.0071
80 ANTERIOR CHAMBER CELL 5 0.0070
81 LACRIMATION INCREASED 210 0.0069
82 OPTIC NERVE INJURY 8 0.0069
83 EYE SWELLING 253 0.0068
84 CYTOMEGALOVIRUS CHORIORETINITIS 13 0.0067
85 EYE INFLAMMATION 63 0.0066
86 PUNCTATE KERATITIS 6 0.0065
87 SWELLING OF EYELID 41 0.0065
88 MUSCLE SWELLING 6 0.0065
89 VITRITIS 12 0.0065
90 PRODUCT DEPOSIT 10 0.0064
91 CYSTOID MACULAR OEDEMA 12 0.0064
92 KYPHOSIS 11 0.0062
93 CONJUNCTIVAL HYPERAEMIA 22 0.0062
94 EYE OEDEMA 15 0.0061
95 CATARACT OPERATION 36 0.0061
96 HYPOPYON 5 0.0060
97 IRITIS 18 0.0059
98 RETINAL VASCULITIS 7 0.0059
99 ULCERATIVE KERATITIS 16 0.0058
100 INSTILLATION SITE REACTION 6 0.0055
101 CONJUNCTIVITIS ALLERGIC 8 0.0054
102 PRODUCT PACKAGE ASSOCIATED INJURY 12 0.0054
103 HAND DEFORMITY 70 0.0053
104 CHROMATOPSIA 4 0.0053
105 RETINAL VEIN OCCLUSION 15 0.0052
106 SCIATICA 83 0.0052
107 EYELID OEDEMA 60 0.0052
108 IRIDOCYCLITIS 16 0.0051
109 CORNEAL DISORDER 11 0.0050
110 MACULAR OEDEMA 28 0.0050
111 CHOROIDAL EFFUSION 4 0.0050
112 HAEMANGIOMA OF LIVER 5 0.0050
113 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 4 0.0049
114 PRODUCT CLOSURE REMOVAL DIFFICULT 5 0.0049
115 OCULAR DISCOMFORT 55 0.0049
116 ABNORMAL SENSATION IN EYE 21 0.0049
117 CIRCADIAN RHYTHM SLEEP DISORDER 4 0.0048
118 EYELID DISORDER 11 0.0048
119 THYROID HORMONES INCREASED 5 0.0048
120 VISUAL FIELD DEFECT 34 0.0047
121 ANGLE CLOSURE GLAUCOMA 12 0.0047
122 VISUAL ACUITY REDUCED 156 0.0047
123 TONIC CLONIC MOVEMENTS 6 0.0046
124 PRODUCT PACKAGING DIFFICULT TO OPEN 12 0.0046
125 AORTIC DILATATION 5 0.0045
126 SYNOVITIS 79 0.0044
127 OPTIC NERVE DISORDER 7 0.0044
128 CERUMEN IMPACTION 4 0.0044
129 DENGUE FEVER 10 0.0044
130 VITREOUS HAEMORRHAGE 12 0.0043
131 VASCULAR PURPURA 6 0.0043
132 OPTIC ATROPHY 7 0.0043
133 EYE INFECTION 48 0.0042
134 RETINAL DISORDER 11 0.0042
135 RETINAL OEDEMA 8 0.0042
136 BLINDNESS UNILATERAL 59 0.0042
137 COCCYDYNIA 6 0.0041
138 PERIORBITAL SWELLING 23 0.0041
139 RETINAL TEAR 10 0.0041
140 STERNAL FRACTURE 5 0.0041
141 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 8 0.0040
142 APRAXIA 6 0.0040
143 PRODUCT CONTAINER SEAL ISSUE 7 0.0040
144 RETINAL ARTERY OCCLUSION 10 0.0040
145 EYE COLOUR CHANGE 4 0.0039
146 DACRYOSTENOSIS ACQUIRED 5 0.0039
147 SKIN REACTION 54 0.0038
148 THYROID DISORDER 59 0.0038
149 RETINAL DETACHMENT 35 0.0038
150 OPTIC NEUROPATHY 8 0.0038
151 PHOTOPHOBIA 70 0.0037
152 BRADYARRHYTHMIA 6 0.0036
153 DEFORMITY 34 0.0036
154 INSTILLATION SITE PAIN 9 0.0036
155 KERATITIS 11 0.0036
156 UVEITIS 48 0.0035
157 EYE OPERATION 16 0.0035
158 INSTILLATION SITE IRRITATION 4 0.0034
159 DIVERTICULITIS 92 0.0033
160 VULVOVAGINAL SWELLING 6 0.0033
161 LEFT ATRIAL DILATATION 4 0.0031
162 AORTIC ARTERIOSCLEROSIS 8 0.0031
163 INTESTINAL POLYP 5 0.0030
164 MYOPIA 7 0.0029
165 ASTHENOPIA 16 0.0029
166 MEDICAL DEVICE REMOVAL 5 0.0029
167 DILATATION VENTRICULAR 6 0.0029
168 EYELID PTOSIS 29 0.0029
169 EXPOSED BONE IN JAW 6 0.0028
170 DARK CIRCLES UNDER EYES 4 0.0027
171 IRON DEFICIENCY ANAEMIA 25 0.0027
172 CATARACT 161 0.0027
173 SPINAL COLUMN INJURY 6 0.0027
174 DRY EYE 129 0.0026
175 SPINAL COLUMN STENOSIS 12 0.0025
176 ENDOPHTHALMITIS 15 0.0025
177 VISION BLURRED 338 0.0025
178 OSTEOLYSIS 5 0.0024
179 DEAFNESS NEUROSENSORY 8 0.0024
180 HYPERPARATHYROIDISM 5 0.0024
181 EYE DISORDER 77 0.0023
182 AUTOIMMUNE HAEMOLYTIC ANAEMIA 8 0.0023
183 BLOOD CHLORIDE DECREASED 6 0.0023
184 CONJUNCTIVITIS 43 0.0023
185 PRODUCT LOT NUMBER ISSUE 5 0.0023
186 PRODUCT DELIVERY MECHANISM ISSUE 12 0.0022
187 PERIARTHRITIS 5 0.0022
188 PATELLA FRACTURE 5 0.0021
189 CONTRAINDICATED PRODUCT ADMINISTERED 64 0.0021
190 CONJUNCTIVAL HAEMORRHAGE 8 0.0021
191 ATRIOVENTRICULAR BLOCK COMPLETE 14 0.0021
192 RADIUS FRACTURE 5 0.0021
193 BLINDNESS TRANSIENT 15 0.0020
194 PRODUCT USE COMPLAINT 32 0.0020
195 EXPIRED DRUG ADMINISTERED 10 0.0020
196 PRODUCT PACKAGING ISSUE 19 0.0020
197 MIXED LIVER INJURY 6 0.0020
198 DYSLIPIDAEMIA 10 0.0020
199 RETINAL HAEMORRHAGE 14 0.0020
200 HYPERSENSITIVITY VASCULITIS 5 0.0019
201 ANAEMIA MACROCYTIC 4 0.0019
202 EYE HAEMORRHAGE 25 0.0019
203 EXOPHTHALMOS 4 0.0019
204 TREATMENT FAILURE 154 0.0019
205 C-REACTIVE PROTEIN INCREASED 67 0.0018
206 BLINDNESS 75 0.0018
207 HAEMORRHAGIC ANAEMIA 8 0.0018
208 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 6 0.0018
209 LIQUID PRODUCT PHYSICAL ISSUE 13 0.0018
210 BRADYCARDIA 94 0.0018
211 HEPATIC CYST 6 0.0018
212 DIABETIC RETINOPATHY 6 0.0018
213 LICHENOID KERATOSIS 4 0.0017
214 PHOTOPSIA 11 0.0017
215 PERIORBITAL OEDEMA 9 0.0017
216 FINE MOTOR SKILL DYSFUNCTION 5 0.0017
217 BONE EROSION 6 0.0017
218 BONE LESION 6 0.0017
219 BRONCHITIS 122 0.0016
220 CUTANEOUS VASCULITIS 6 0.0016
221 RENAL CYST 13 0.0016
222 LEFT VENTRICULAR HYPERTROPHY 7 0.0016
223 VITREOUS FLOATERS 16 0.0016
224 NECROSIS 9 0.0016
225 DIVERTICULUM INTESTINAL 7 0.0016
226 PHYSICAL DISABILITY 7 0.0016
227 BLOOD PRESSURE DIASTOLIC ABNORMAL 4 0.0016
228 NEPHROGENIC ANAEMIA 7 0.0015
229 EXPOSURE DURING BREAST FEEDING 5 0.0015
230 MACULAR DEGENERATION 18 0.0015
231 CYTOLYTIC HEPATITIS 5 0.0015
232 BLOOD PRESSURE INADEQUATELY CONTROLLED 9 0.0015
233 VISUAL IMPAIRMENT 182 0.0015
234 HEART RATE DECREASED 51 0.0015
235 HEART RATE IRREGULAR 32 0.0014
236 BUNDLE BRANCH BLOCK LEFT 6 0.0014
237 AORTIC VALVE INCOMPETENCE 6 0.0014
238 DIVERTICULUM 10 0.0014
239 CARDIAC VALVE DISEASE 8 0.0014
240 VISUAL DISTURBANCE 8 0.0014
241 BLOOD MAGNESIUM DECREASED 12 0.0014
242 HYPOGLYCAEMIC COMA 4 0.0014
243 HEPATIC LESION 6 0.0014
244 LUMBAR SPINAL STENOSIS 4 0.0014
245 FOOD INTOLERANCE 5 0.0014
246 BENIGN PROSTATIC HYPERPLASIA 7 0.0014
247 BLOOD PRESSURE DIASTOLIC DECREASED 10 0.0014
248 SINUS BRADYCARDIA 13 0.0013
249 CEREBROVASCULAR DISORDER 4 0.0013
250 OPTIC NEURITIS 12 0.0013
251 PRODUCT STORAGE ISSUE 5 0.0013
252 ATRIOVENTRICULAR BLOCK SECOND DEGREE 4 0.0013
253 OSTEOPENIA 20 0.0013
254 INTERVERTEBRAL DISC DEGENERATION 12 0.0013
255 CARDIAC MURMUR 11 0.0013
256 HYPERKERATOSIS 7 0.0013
257 TRICUSPID VALVE INCOMPETENCE 10 0.0013
258 SPINAL OSTEOARTHRITIS 11 0.0013
259 SKIN PAPILLOMA 5 0.0012
260 MIOSIS 10 0.0012
261 LOOSE TOOTH 4 0.0012
262 MYASTHENIA GRAVIS 10 0.0012
263 NEUROLOGICAL SYMPTOM 7 0.0012
264 SPINAL STENOSIS 5 0.0012
265 ORTHOSTATIC HYPOTENSION 21 0.0012
266 HYPERSENSITIVITY 220 0.0012
267 PURULENT DISCHARGE 5 0.0012
268 DRUG INTOLERANCE 113 0.0012
269 WRIST FRACTURE 14 0.0012
270 HORDEOLUM 5 0.0012
271 HYPONATRAEMIA 65 0.0012
272 AORTIC STENOSIS 4 0.0011
273 CAROTID ARTERY STENOSIS 4 0.0011
274 INCORRECT PRODUCT STORAGE 15 0.0011
275 ONYCHOMYCOSIS 5 0.0011
276 NASAL DISCOMFORT 9 0.0011
277 LUNG INFILTRATION 10 0.0011
278 FACIAL PAIN 10 0.0011
279 PRODUCT RESIDUE PRESENT 6 0.0011
280 SYNCOPE 111 0.0011
281 HYPOTONIA 11 0.0011
282 ARRHYTHMIA 52 0.0011
283 EXOSTOSIS 10 0.0011
284 TOOTH FRACTURE 12 0.0011
285 ANOREXIA 14 0.0011
286 INCOHERENT 7 0.0011
287 GASTRITIS EROSIVE 5 0.0011
288 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 11 0.0011
289 PRODUCT QUALITY ISSUE 145 0.0011
290 CHRONIC SINUSITIS 4 0.0011
291 ARTERIOSCLEROSIS 10 0.0011
292 INJECTION SITE REACTION 72 0.0010
293 FAECAL INCONTINENCE 5 0.0010
294 SKIN WARM 6 0.0010
295 DYSGEUSIA 76 0.0010
296 BREATH SOUNDS ABNORMAL 5 0.0010
297 HYPERLIPIDAEMIA 12 0.0010
298 CEREBRAL ATROPHY 4 0.0010
299 ATRIAL FLUTTER 8 0.0010
300 INTERNATIONAL NORMALISED RATIO DECREASED 4 0.0010
301 MENISCUS INJURY 6 0.0010
302 CARDIOMEGALY 12 0.0010
303 ESCHERICHIA INFECTION 8 0.0010
304 MITRAL VALVE INCOMPETENCE 11 0.0010
305 PRODUCT SUBSTITUTION ISSUE 55 0.0010
306 GINGIVAL BLEEDING 13 0.0010
307 POOR QUALITY DRUG ADMINISTERED 6 0.0009
308 EAR PAIN 18 0.0009
309 AGEUSIA 23 0.0009
310 ACCIDENT 11 0.0009
311 HEPATOCELLULAR CARCINOMA 7 0.0009
312 AORTIC ANEURYSM 7 0.0009
313 PULMONARY HYPERTENSION 19 0.0009
314 GINGIVAL SWELLING 4 0.0009
315 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0009
316 ABDOMINAL ABSCESS 4 0.0009
317 HEART RATE ABNORMAL 5 0.0009
318 HAEMORRHAGIC STROKE 7 0.0009
319 HEPATIC ENZYME INCREASED 61 0.0009
320 EMPHYSEMA 9 0.0009
321 ACUTE RESPIRATORY FAILURE 17 0.0009
322 OSTEOMYELITIS 16 0.0009
323 MICTURITION URGENCY 10 0.0009
324 PERIPHERAL COLDNESS 12 0.0009
325 ENCEPHALITIS 6 0.0009
326 UROSEPSIS 8 0.0009
327 CHRONIC MYELOID LEUKAEMIA 4 0.0009
328 BLOOD CHOLESTEROL ABNORMAL 4 0.0009
329 HYPOPHAGIA 22 0.0009
330 HYPERKALAEMIA 30 0.0009
331 HYPOVOLAEMIA 5 0.0009
332 URINE ODOUR ABNORMAL 5 0.0008
333 HIATUS HERNIA 11 0.0008
334 MOBILITY DECREASED 61 0.0008
335 DIPLOPIA 22 0.0008
336 CARDIAC PACEMAKER INSERTION 5 0.0008
337 HEARING IMPAIRED 5 0.0008
338 BASAL CELL CARCINOMA 13 0.0008
339 POST PROCEDURAL COMPLICATION 16 0.0008
340 SOPOR 11 0.0008
341 ATELECTASIS 8 0.0008
342 CHOLELITHIASIS 27 0.0008
343 TENSION 5 0.0008
344 VITAMIN D DEFICIENCY 8 0.0008
345 HAEMORRHOIDS 16 0.0008
346 VITAMIN D DECREASED 7 0.0008
347 SKIN HYPERPIGMENTATION 7 0.0008
348 ATRIAL FIBRILLATION 79 0.0008
349 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
350 ANGINA PECTORIS 23 0.0008
351 RENAL FAILURE ACUTE 34 0.0008
352 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 6 0.0008
353 FLUID INTAKE REDUCED 4 0.0008
354 NASAL DRYNESS 5 0.0008
355 DERMATITIS ALLERGIC 10 0.0008
356 GAIT DISTURBANCE 152 0.0008
357 BLEPHAROSPASM 5 0.0008
358 MUSCULAR WEAKNESS 90 0.0008
359 PURPURA 7 0.0008
360 HYPOTHERMIA 8 0.0008
361 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
362 SCAB 9 0.0008
363 PRESYNCOPE 19 0.0008
364 ROTATOR CUFF SYNDROME 10 0.0008
365 CEREBRAL ISCHAEMIA 4 0.0008
366 HAEMATOMA 20 0.0008
367 GASTROINTESTINAL CARCINOMA 7 0.0008
368 FACE OEDEMA 13 0.0008
369 FAILURE TO THRIVE 4 0.0008
370 VENTRICULAR EXTRASYSTOLES 8 0.0008
371 HYPERGLYCAEMIA 28 0.0008
372 RHEUMATOID ARTHRITIS 87 0.0008
373 POLYP 5 0.0008
374 HYPERTENSION 161 0.0008
375 NERVE COMPRESSION 7 0.0008
376 HALLUCINATION, VISUAL 16 0.0008
377 HYPOKINESIA 11 0.0008
378 CORONAVIRUS INFECTION 5 0.0008
379 MUSCULOSKELETAL DISCOMFORT 13 0.0008
380 OSTEOARTHRITIS 32 0.0008
381 ABSCESS 12 0.0008
382 CARDIAC FAILURE ACUTE 5 0.0007
383 BODY HEIGHT DECREASED 8 0.0007
384 DYSPNOEA EXERTIONAL 28 0.0007
385 BLOOD URINE PRESENT 14 0.0007
386 DECUBITUS ULCER 6 0.0007
387 DIABETES MELLITUS INADEQUATE CONTROL 13 0.0007
388 HYPOGLYCAEMIA 35 0.0007
389 HYPERTENSIVE CRISIS 8 0.0007
390 EXTRASYSTOLES 5 0.0007
391 HIP FRACTURE 23 0.0007
392 MALNUTRITION 8 0.0007
393 DYSURIA 26 0.0007
394 SWOLLEN TONGUE 22 0.0007
395 DERMATITIS CONTACT 8 0.0007
396 MYOPATHY 6 0.0007
397 PYELONEPHRITIS 6 0.0007
398 GROIN PAIN 6 0.0007
399 TUMOUR LYSIS SYNDROME 6 0.0007
400 MELAENA 15 0.0007
401 BLOOD PRESSURE INCREASED 104 0.0007
402 INFLAMMATION 35 0.0007
403 HEAD DISCOMFORT 12 0.0007
404 CARDIAC FAILURE 54 0.0007
405 MYOSITIS 6 0.0007
406 CONFUSIONAL STATE 108 0.0007
407 BLOOD PRESSURE SYSTOLIC INCREASED 13 0.0007
408 INTERNATIONAL NORMALISED RATIO INCREASED 19 0.0007
409 SINUS CONGESTION 9 0.0007
410 PHOTOSENSITIVITY REACTION 11 0.0007
411 RHINORRHOEA 43 0.0007
412 CORONARY ARTERY DISEASE 20 0.0007
413 BONE DISORDER 12 0.0007
414 FALL 219 0.0007
415 FOETAL GROWTH RESTRICTION 4 0.0007
416 LOSS OF CONSCIOUSNESS 84 0.0007
417 HAEMATOCRIT DECREASED 13 0.0007
418 PHARMACEUTICAL PRODUCT COMPLAINT 17 0.0007
419 ABNORMAL DREAMS 18 0.0007
420 DYSSTASIA 19 0.0007
421 PHARYNGEAL OEDEMA 10 0.0006
422 FOOD ALLERGY 5 0.0006
423 DEMENTIA 18 0.0006
424 DELUSION 10 0.0006
425 PRODUCT ADMINISTRATION ERROR 13 0.0006
426 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
427 ARTERIAL OCCLUSIVE DISEASE 5 0.0006
428 LEUKAEMIA 6 0.0006
429 GAMMA-GLUTAMYLTRANSFERASE INCREASED 14 0.0006
430 FOOT DEFORMITY 7 0.0006
431 RECTAL HAEMORRHAGE 27 0.0006
432 HYPOKALAEMIA 29 0.0006
433 GINGIVAL PAIN 5 0.0006
434 CARDIOGENIC SHOCK 9 0.0006
435 GLOSSODYNIA 14 0.0006
436 C-REACTIVE PROTEIN ABNORMAL 4 0.0006
437 DRUG DOSE OMISSION 103 0.0006
438 BLOOD CALCIUM DECREASED 7 0.0006
439 DERMATITIS 13 0.0006
440 MUSCLE DISORDER 5 0.0006
441 FEELING COLD 17 0.0006
442 TINNITUS 28 0.0006
443 OEDEMA PERIPHERAL 74 0.0006
444 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
445 BALANCE DISORDER 52 0.0006
446 SECOND PRIMARY MALIGNANCY 5 0.0006
447 RASH MACULAR 21 0.0006
448 BLOOD CHOLESTEROL INCREASED 28 0.0006
449 DYSPHONIA 35 0.0006
450 PNEUMOCYSTIS JIROVECII PNEUMONIA 6 0.0006
451 BLOOD GLUCOSE ABNORMAL 11 0.0006
452 CELLULITIS 30 0.0006
453 ECONOMIC PROBLEM 9 0.0006
454 PRODUCT COMPLAINT 15 0.0006
455 BACTERAEMIA 7 0.0006
456 CHOLECYSTITIS 7 0.0006
457 DRUG ADMINISTRATION ERROR 18 0.0006
458 URINARY TRACT INFECTION 100 0.0006
459 NO ADVERSE EVENT 106 0.0006
460 BLOOD TESTOSTERONE DECREASED 4 0.0006
461 BLOOD SODIUM DECREASED 11 0.0006
462 ECCHYMOSIS 4 0.0006
463 LYMPHOMA 9 0.0006
464 JOINT EFFUSION 4 0.0006
465 PSYCHOLOGICAL TRAUMA 5 0.0006
466 HAIR GROWTH ABNORMAL 4 0.0006
467 SLEEP APNOEA SYNDROME 11 0.0006
468 ACUTE KIDNEY INJURY 88 0.0006
469 CARPAL TUNNEL SYNDROME 8 0.0006
470 LIP SWELLING 19 0.0006
471 BLOOD CALCIUM INCREASED 5 0.0006
472 URINARY RETENTION 19 0.0006
473 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
474 OSTEONECROSIS OF JAW 14 0.0006
475 HAND FRACTURE 4 0.0006
476 PHARYNGITIS 7 0.0006
477 HYPOTHYROIDISM 18 0.0006
478 EPISTAXIS 42 0.0006
479 WRONG DRUG ADMINISTERED 5 0.0006
480 GALLBLADDER DISORDER 10 0.0006
481 SKIN CANCER 12 0.0006
482 BURNING SENSATION 39 0.0006
483 ACTIVITIES OF DAILY LIVING IMPAIRED 11 0.0006
484 PRURITUS GENERALISED 12 0.0006
485 HAEMATURIA 19 0.0006
486 MUSCULOSKELETAL PAIN 29 0.0006
487 OROPHARYNGEAL DISCOMFORT 5 0.0006
488 BACK DISORDER 9 0.0006
489 MUSCLE ATROPHY 7 0.0006
490 POLLAKIURIA 23 0.0006
491 LIMB DISCOMFORT 17 0.0005
492 INTENTIONAL UNDERDOSE 4 0.0005
493 UNRESPONSIVE TO STIMULI 14 0.0005
494 BLOOD PRESSURE FLUCTUATION 13 0.0005
495 CARDIOMYOPATHY 8 0.0005
496 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
497 URINARY INCONTINENCE 16 0.0005
498 BODY TEMPERATURE INCREASED 11 0.0005
499 ASTHENIA 202 0.0005
500 UPPER GASTROINTESTINAL HAEMORRHAGE 9 0.0005
501 RIB FRACTURE 11 0.0005
502 CYSTITIS 17 0.0005
503 TRANSIENT ISCHAEMIC ATTACK 18 0.0005
504 GASTRITIS 14 0.0005
505 METABOLIC ACIDOSIS 17 0.0005
506 DRY MOUTH 43 0.0005
507 ADVERSE REACTION 7 0.0005
508 NASAL CONGESTION 31 0.0005
509 MYOCARDIAL ISCHAEMIA 6 0.0005
510 BLOOD PRESSURE DECREASED 35 0.0005
511 NEPHROLITHIASIS 24 0.0005
512 SWELLING FACE 34 0.0005
513 LIPASE INCREASED 4 0.0005
514 PNEUMONIA 168 0.0005
515 HALLUCINATION 39 0.0005
516 LOCAL SWELLING 9 0.0005
517 APHTHOUS ULCER 4 0.0005
518 SPLENOMEGALY 6 0.0005
519 HYPOACUSIS 22 0.0005
520 CARDIAC FAILURE CONGESTIVE 41 0.0005
521 SKIN LESION 14 0.0005
522 ADVERSE EVENT 47 0.0005
523 LIGAMENT SPRAIN 5 0.0005
524 SINUS DISORDER 10 0.0005
525 DISORIENTATION 20 0.0005
526 DRUG INTERACTION 80 0.0005
527 INTESTINAL OBSTRUCTION 19 0.0005
528 ORAL DISCOMFORT 7 0.0005
529 RHABDOMYOLYSIS 21 0.0005
530 OBESITY 8 0.0005
531 GOUT 9 0.0005
532 SKIN DISCOLOURATION 23 0.0005
533 RENAL IMPAIRMENT 42 0.0005
534 DIABETES MELLITUS 38 0.0005
535 LEUKOCYTOSIS 9 0.0005
536 DEAFNESS 13 0.0005
537 TOOTHACHE 9 0.0005
538 BURSITIS 6 0.0005
539 END STAGE RENAL DISEASE 9 0.0005
540 VERTIGO 30 0.0005
541 ACCIDENTAL OVERDOSE 18 0.0005
542 CARDIAC DISORDER 46 0.0005
543 SUBARACHNOID HAEMORRHAGE 5 0.0005
544 BRONCHOSPASM 7 0.0005
545 SNEEZING 11 0.0005
546 ASPHYXIA 4 0.0005
547 ABNORMAL FAECES 4 0.0005
548 HICCUPS 4 0.0005
549 IMPAIRED HEALING 16 0.0005
550 CONDITION AGGRAVATED 148 0.0005
551 OSTEOPOROSIS 20 0.0005
552 MYELODYSPLASTIC SYNDROME 7 0.0005
553 MIDDLE INSOMNIA 9 0.0005
554 HEMIPLEGIA 4 0.0005
555 TENDERNESS 5 0.0005
556 GASTROINTESTINAL HAEMORRHAGE 40 0.0005
557 ERYTHEMA 98 0.0005
558 DISCOMFORT 29 0.0005
559 SKIN EXFOLIATION 40 0.0005
560 WHEEZING 28 0.0005
561 ANAEMIA 90 0.0005
562 LOWER LIMB FRACTURE 9 0.0005
563 DYSPNOEA 265 0.0005
564 THROAT IRRITATION 21 0.0005
565 HAEMOGLOBIN DECREASED 48 0.0005
566 CARDIAC OPERATION 4 0.0005
567 POOR QUALITY SLEEP 10 0.0005
568 BLISTER 26 0.0005
569 OEDEMA 25 0.0005
570 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
571 PLATELET COUNT INCREASED 6 0.0005
572 BACK INJURY 5 0.0005
573 BLOOD CREATININE INCREASED 30 0.0005
574 FLATULENCE 26 0.0005
575 DEHYDRATION 61 0.0005
576 WOUND INFECTION 5 0.0005
577 GASTROINTESTINAL PAIN 5 0.0005
578 BLOOD PRESSURE ABNORMAL 9 0.0005
579 MUSCULOSKELETAL CHEST PAIN 7 0.0005
580 FEMUR FRACTURE 14 0.0005
581 UPPER LIMB FRACTURE 9 0.0005
582 EXPIRED PRODUCT ADMINISTERED 15 0.0005
583 CEREBRAL INFARCTION 11 0.0004
584 DRUG INEFFECTIVE 593 0.0004
585 JOINT RANGE OF MOTION DECREASED 6 0.0004
586 CEREBRAL HAEMORRHAGE 16 0.0004
587 HYPOTENSION 89 0.0004
588 TASTE DISORDER 9 0.0004
589 OROPHARYNGEAL PAIN 41 0.0004
590 PNEUMOTHORAX 7 0.0004
591 PNEUMONITIS 12 0.0004
592 SPEECH DISORDER 23 0.0004
593 CORONARY ARTERY OCCLUSION 6 0.0004
594 DIZZINESS 218 0.0004
595 RENAL FAILURE 58 0.0004
596 COUGH 122 0.0004
597 RESPIRATORY DISORDER 13 0.0004
598 HEART RATE INCREASED 43 0.0004
599 GRAND MAL CONVULSION 4 0.0004
600 BLOOD POTASSIUM DECREASED 13 0.0004
601 PARAESTHESIA 68 0.0004
602 MENTAL STATUS CHANGES 12 0.0004
603 BLOOD POTASSIUM INCREASED 7 0.0004
604 MADAROSIS 5 0.0004
605 AMNESIA 28 0.0004
606 MYOCARDIAL INFARCTION 75 0.0004
607 CHEST DISCOMFORT 44 0.0004
608 ANGIOEDEMA 19 0.0004
609 CAESAREAN SECTION 5 0.0004
610 APPENDICITIS 4 0.0004
611 PALPITATIONS 50 0.0004
612 RESPIRATORY TRACT INFECTION 11 0.0004
613 FOOT FRACTURE 8 0.0004
614 ATAXIA 5 0.0004
615 COAGULOPATHY 7 0.0004
616 ALOPECIA 82 0.0004
617 IMPAIRED QUALITY OF LIFE 6 0.0004
618 LETHARGY 24 0.0004
619 BLOOD GLUCOSE DECREASED 20 0.0004
620 WEIGHT DECREASED 116 0.0004
621 CANDIDA INFECTION 7 0.0004
622 HERNIA 8 0.0004
623 LOCALISED INFECTION 10 0.0004
624 ADRENAL INSUFFICIENCY 5 0.0004
625 NOCTURIA 5 0.0004
626 RESPIRATORY FAILURE 30 0.0004
627 GASTROENTERITIS 6 0.0004
628 SCAR 7 0.0004
629 ASCITES 12 0.0004
630 HYPOAESTHESIA 61 0.0004
631 HEPATOMEGALY 4 0.0004
632 GENERAL PHYSICAL HEALTH DETERIORATION 47 0.0004
633 SPINAL OPERATION 5 0.0004
634 HOSPICE CARE 4 0.0004
635 HYPERCALCAEMIA 5 0.0004
636 THROMBOCYTOPENIA 45 0.0004
637 ABDOMINAL DISTENSION 42 0.0004
638 TOOTH EXTRACTION 5 0.0004
639 RASH PAPULAR 9 0.0004
640 DEVICE USE ISSUE 7 0.0004
641 LEUKOPENIA 20 0.0004
642 HYPOAESTHESIA ORAL 6 0.0004
643 HEPATIC FAILURE 12 0.0004
644 PRODUCT PHYSICAL ISSUE 8 0.0004
645 LYMPHOCYTE COUNT DECREASED 7 0.0004
646 PLEURAL EFFUSION 24 0.0004
647 HAEMOPTYSIS 11 0.0004
648 CHEST PAIN 73 0.0004
649 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 28 0.0004
650 DRY THROAT 4 0.0004
651 FLUID RETENTION 20 0.0004
652 DEATH 338 0.0004
653 ISCHAEMIC STROKE 7 0.0004
654 ALANINE AMINOTRANSFERASE INCREASED 24 0.0004
655 SINUSITIS 40 0.0004
656 ERECTILE DYSFUNCTION 10 0.0004
657 LUNG DISORDER 19 0.0004
658 SKIN ULCER 10 0.0004
659 TYPE 2 DIABETES MELLITUS 13 0.0004
660 THERAPY PARTIAL RESPONDER 6 0.0004
661 BEDRIDDEN 5 0.0004
662 DYSPHAGIA 36 0.0004
663 PULMONARY CONGESTION 5 0.0004
664 HEAD INJURY 12 0.0004
665 MEMORY IMPAIRMENT 52 0.0004
666 FULL BLOOD COUNT ABNORMAL 4 0.0004
667 CEREBROVASCULAR ACCIDENT 64 0.0004
668 ASPARTATE AMINOTRANSFERASE INCREASED 20 0.0004
669 SENSORY DISTURBANCE 6 0.0004
670 DYSARTHRIA 14 0.0004
671 FEAR 10 0.0004
672 SKIN IRRITATION 17 0.0004
673 MYALGIA 63 0.0004
674 INJURY 26 0.0004
675 HYPOXIA 13 0.0004
676 GASTRIC ULCER 7 0.0004
677 VOMITING 173 0.0004
678 SOMNOLENCE 74 0.0004
679 DRUG TOXICITY 5 0.0004
680 HEADACHE 230 0.0004
681 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
682 DECREASED APPETITE 85 0.0004
683 BLOOD GLUCOSE FLUCTUATION 4 0.0004
684 ABASIA 9 0.0004
685 VENTRICULAR TACHYCARDIA 6 0.0004
686 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
687 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
688 PRESCRIBED OVERDOSE 7 0.0004
689 THROMBOSIS 29 0.0004
690 STEVENS-JOHNSON SYNDROME 8 0.0004
691 ARTHROPATHY 20 0.0004
692 MEDICATION ERROR 20 0.0004
693 HUNGER 5 0.0004
694 SURGERY 21 0.0004
695 WRONG TECHNIQUE IN DRUG USAGE PROCESS 13 0.0004
696 WOUND 10 0.0004
697 CONSTIPATION 78 0.0004
698 ORAL PAIN 8 0.0004
699 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
700 ARTHRITIS 28 0.0004
701 ARTHRALGIA 148 0.0004
702 RESTLESSNESS 13 0.0004
703 FATIGUE 276 0.0004
704 SLEEP DISORDER 25 0.0004
705 LYMPHOPENIA 5 0.0004
706 SEASONAL ALLERGY 5 0.0004
707 PAIN IN JAW 10 0.0004
708 DIALYSIS 5 0.0004
709 CARDIAC ARREST 29 0.0004
710 PERIPHERAL SWELLING 54 0.0004
711 RED BLOOD CELL COUNT DECREASED 10 0.0003
712 GASTRIC DISORDER 12 0.0003
713 ACCIDENTAL EXPOSURE TO PRODUCT 36 0.0003
714 SUBDURAL HAEMATOMA 5 0.0003
715 ANOSMIA 5 0.0003
716 DRY SKIN 46 0.0003
717 APATHY 5 0.0003
718 COGNITIVE DISORDER 16 0.0003
719 FEELING HOT 21 0.0003
720 ANHEDONIA 9 0.0003
721 CHRONIC KIDNEY DISEASE 26 0.0003
722 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
723 PLATELET COUNT DECREASED 36 0.0003
724 PRODUCT DOSE OMISSION ISSUE 99 0.0003
725 BACK PAIN 78 0.0003
726 PULMONARY MASS 5 0.0003
727 COLON CANCER 5 0.0003
728 GASTROOESOPHAGEAL REFLUX DISEASE 27 0.0003
729 PRODUCTIVE COUGH 16 0.0003
730 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
731 ROAD TRAFFIC ACCIDENT 14 0.0003
732 BLOOD BILIRUBIN INCREASED 9 0.0003
733 CONTUSION 32 0.0003
734 SWELLING 31 0.0003
735 RASH 144 0.0003
736 RESTLESS LEGS SYNDROME 6 0.0003
737 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 6 0.0003
738 INSOMNIA 87 0.0003
739 PRODUCT USE ISSUE 61 0.0003
740 ABDOMINAL PAIN 75 0.0003
741 APPLICATION SITE IRRITATION 4 0.0003
742 CYANOSIS 5 0.0003
743 NIGHTMARE 11 0.0003
744 FRACTURE 6 0.0003
745 COLITIS 12 0.0003
746 DIARRHOEA 204 0.0003
747 PAIN 194 0.0003
748 LIVER DISORDER 14 0.0003
749 CHILLS 37 0.0003
750 DRUG EFFECT DECREASED 17 0.0003
751 PROTEINURIA 6 0.0003
752 FEELING JITTERY 6 0.0003
753 RESPIRATORY TRACT CONGESTION 5 0.0003
754 HALLUCINATION, AUDITORY 5 0.0003
755 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
756 THERAPY NON-RESPONDER 14 0.0003
757 PANCREATITIS ACUTE 7 0.0003
758 CARDIO-RESPIRATORY ARREST 13 0.0003
759 ORAL HERPES 6 0.0003
760 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 16 0.0003
761 ELECTROCARDIOGRAM QT PROLONGED 11 0.0003
762 JOINT STIFFNESS 8 0.0003
763 METASTASES TO BONE 5 0.0003
764 PRURITUS 117 0.0003
765 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
766 CYTOMEGALOVIRUS INFECTION 5 0.0003
767 PRESCRIBED UNDERDOSE 6 0.0003
768 ABORTION SPONTANEOUS 12 0.0003
769 GAIT INABILITY 10 0.0003
770 BLOOD UREA INCREASED 5 0.0003
771 MALIGNANT MELANOMA 4 0.0003
772 STOMATITIS 18 0.0003
773 FLUSHING 30 0.0003
774 LIMB INJURY 8 0.0003
775 NEUTROPHIL COUNT DECREASED 12 0.0003
776 DISEASE RECURRENCE 14 0.0003
777 IMPAIRED GASTRIC EMPTYING 4 0.0003
778 TACHYCARDIA 26 0.0003
779 ASTHMA 33 0.0003
780 ANXIETY 83 0.0003
781 DIABETIC KETOACIDOSIS 7 0.0003
782 DEPRESSION 66 0.0003
783 HYPOMAGNESAEMIA 4 0.0003
784 COORDINATION ABNORMAL 4 0.0003
785 OFF LABEL USE 251 0.0003
786 MASS 4 0.0003
787 INTENTIONAL PRODUCT MISUSE 25 0.0003
788 PAIN IN EXTREMITY 84 0.0003
789 METASTASES TO LIVER 5 0.0003
790 PULMONARY EMBOLISM 27 0.0003
791 DISSEMINATED INTRAVASCULAR COAGULATION 4 0.0003
792 DRUG ERUPTION 5 0.0003
793 RETCHING 6 0.0003
794 JOINT INJURY 6 0.0003
795 IRRITABLE BOWEL SYNDROME 6 0.0003
796 HYPERHIDROSIS 36 0.0003
797 DISEASE PROGRESSION 33 0.0003
798 HERPES ZOSTER 16 0.0003
799 LACTIC ACIDOSIS 9 0.0003
800 BLOOD CREATINE PHOSPHOKINASE INCREASED 8 0.0003
801 HAEMATEMESIS 7 0.0003
802 PELVIC PAIN 5 0.0003
803 LIVER FUNCTION TEST ABNORMAL 8 0.0003
804 FLUID OVERLOAD 4 0.0003
805 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
806 APPLICATION SITE PAIN 6 0.0003
807 NAUSEA 215 0.0003
808 AGRANULOCYTOSIS 5 0.0003
809 SEPSIS 30 0.0003
810 PANCYTOPENIA 15 0.0003
811 HAEMORRHAGE INTRACRANIAL 4 0.0003
812 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
813 BONE LOSS 4 0.0003
814 APHASIA 8 0.0003
815 UNEVALUABLE EVENT 20 0.0003
816 PRODUCT AVAILABILITY ISSUE 6 0.0003
817 EAR INFECTION 7 0.0003
818 ABDOMINAL PAIN UPPER 54 0.0003
819 COVID-19 46 0.0003
820 EPILEPSY 8 0.0003
821 DEEP VEIN THROMBOSIS 17 0.0003
822 PULMONARY FIBROSIS 5 0.0003
823 CHOLESTASIS 5 0.0003
824 UNDERDOSE 19 0.0003
825 DEVICE RELATED INFECTION 4 0.0003
826 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
827 DELIRIUM 9 0.0003
828 FREQUENT BOWEL MOVEMENTS 7 0.0003
829 WEIGHT INCREASED 58 0.0003
830 JOINT SWELLING 31 0.0003
831 PLASMA CELL MYELOMA 10 0.0003
832 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 46 0.0003
833 NASOPHARYNGITIS 47 0.0003
834 KIDNEY INFECTION 5 0.0003
835 BLOOD GLUCOSE INCREASED 48 0.0003
836 LYMPHADENOPATHY 9 0.0003
837 INCORRECT DOSE ADMINISTERED 58 0.0003
838 HAEMATOCHEZIA 14 0.0003
839 PROCEDURAL PAIN 7 0.0003
840 COMA 12 0.0003
841 PRODUCT PRESCRIBING ERROR 6 0.0003
842 MUSCULOSKELETAL STIFFNESS 22 0.0003
843 NECK PAIN 14 0.0003
844 FEELING ABNORMAL 60 0.0003
845 NIGHT SWEATS 8 0.0002
846 EMOTIONAL DISTRESS 30 0.0002
847 EXTRA DOSE ADMINISTERED 10 0.0002
848 FIBROMYALGIA 6 0.0002
849 DYSKINESIA 10 0.0002
850 PYREXIA 85 0.0002
851 PULMONARY OEDEMA 11 0.0002
852 LUNG NEOPLASM MALIGNANT 10 0.0002
853 NEUROPATHY PERIPHERAL 23 0.0002
854 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
855 PRODUCT STORAGE ERROR 21 0.0002
856 SKIN DISORDER 8 0.0002
857 NEOPLASM MALIGNANT 16 0.0002
858 MALAISE 105 0.0002
859 HOT FLUSH 18 0.0002
860 ACUTE MYOCARDIAL INFARCTION 7 0.0002
861 ABDOMINAL PAIN LOWER 6 0.0002
862 HEMIPARESIS 4 0.0002
863 RENAL DISORDER 11 0.0002
864 CIRCULATORY COLLAPSE 4 0.0002
865 DYSPEPSIA 23 0.0002
866 LIVER FUNCTION TEST INCREASED 5 0.0002
867 URTICARIA 39 0.0002
868 ANAPHYLACTIC SHOCK 6 0.0002
869 ABDOMINAL DISCOMFORT 39 0.0002
870 AGITATION 17 0.0002
871 RASH ERYTHEMATOUS 11 0.0002
872 HAEMORRHAGE 24 0.0002
873 ECZEMA 12 0.0002
874 EOSINOPHILIA 4 0.0002
875 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
876 ABNORMAL BEHAVIOUR 9 0.0002
877 EMOTIONAL DISORDER 7 0.0002
878 FEBRILE NEUTROPENIA 15 0.0002
879 TRANSAMINASES INCREASED 5 0.0002
880 INFLUENZA 25 0.0002
881 BONE DENSITY DECREASED 7 0.0002
882 TREMOR 37 0.0002
883 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
884 ADVERSE DRUG REACTION 20 0.0002
885 GASTROENTERITIS VIRAL 4 0.0002
886 PALLOR 6 0.0002
887 RESPIRATORY DISTRESS 6 0.0002
888 MUSCLE TWITCHING 5 0.0002
889 PERICARDIAL EFFUSION 5 0.0002
890 HEPATIC STEATOSIS 4 0.0002
891 BACTERIAL INFECTION 4 0.0002
892 INFECTION 31 0.0002
893 INCORRECT DRUG ADMINISTRATION DURATION 6 0.0002
894 HEPATIC CIRRHOSIS 4 0.0002
895 GASTROINTESTINAL DISORDER 19 0.0002
896 FUNGAL INFECTION 7 0.0002
897 INCREASED APPETITE 4 0.0002
898 HYPERSOMNIA 6 0.0002
899 MULTIPLE SCLEROSIS 10 0.0002
900 DRUG PRESCRIBING ERROR 4 0.0002
901 ANGER 7 0.0002
902 INTERSTITIAL LUNG DISEASE 10 0.0002
903 DRUG EXPOSURE DURING PREGNANCY 7 0.0002
904 NEURALGIA 5 0.0002
905 CHOKING 4 0.0002
906 BONE PAIN 12 0.0002
907 RASH PRURITIC 11 0.0002
908 WHITE BLOOD CELL COUNT DECREASED 22 0.0002
909 RENAL INJURY 6 0.0002
910 TREATMENT NONCOMPLIANCE 11 0.0002
911 COMPLICATION OF DEVICE INSERTION 4 0.0002
912 PNEUMONIA ASPIRATION 5 0.0002
913 MIGRAINE 19 0.0002
914 PROSTATE CANCER 16 0.0002
915 FULL BLOOD COUNT DECREASED 4 0.0002
916 FEEDING DISORDER 4 0.0002
917 CARDIOVASCULAR DISORDER 5 0.0002
918 BONE MARROW FAILURE 4 0.0002
919 THERAPY INTERRUPTED 14 0.0002
920 OXYGEN SATURATION DECREASED 11 0.0002
921 RASH GENERALISED 5 0.0002
922 EXPOSURE VIA SKIN CONTACT 5 0.0002
923 DRUG EFFECT INCOMPLETE 7 0.0002
924 NEUTROPENIA 26 0.0002
925 APPLICATION SITE ERYTHEMA 5 0.0002
926 MUSCLE SPASMS 35 0.0002
927 MOUTH ULCERATION 4 0.0002
928 DEPRESSED MOOD 10 0.0002
929 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 38 0.0002
930 JAUNDICE 5 0.0002
931 DISTURBANCE IN ATTENTION 10 0.0002
932 THROAT TIGHTNESS 5 0.0002
933 MENTAL DISORDER 8 0.0002
934 IRRITABILITY 11 0.0002
935 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
936 OSTEONECROSIS 6 0.0002
937 INTENTIONAL PRODUCT USE ISSUE 16 0.0002
938 STAPHYLOCOCCAL INFECTION 6 0.0002
939 THERAPEUTIC RESPONSE DECREASED 11 0.0002
940 CHROMATURIA 4 0.0002
941 SEIZURE 20 0.0002
942 ACNE 13 0.0002
943 LABORATORY TEST ABNORMAL 5 0.0002
944 HOSPITALISATION 26 0.0002
945 PRODUCT DOSE OMISSION 11 0.0002
946 PRODUCT ADHESION ISSUE 6 0.0002
947 SKIN BURNING SENSATION 12 0.0002
948 CRYING 6 0.0002
949 MENTAL IMPAIRMENT 4 0.0002
950 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0002
951 SEPTIC SHOCK 7 0.0002
952 NERVOUS SYSTEM DISORDER 5 0.0002
953 INFLUENZA LIKE ILLNESS 13 0.0002
954 MALIGNANT NEOPLASM PROGRESSION 16 0.0002
955 THERAPY CESSATION 8 0.0002
956 NERVOUSNESS 8 0.0002
957 OVERDOSE 32 0.0001
958 ILL-DEFINED DISORDER 9 0.0001
959 PSORIATIC ARTHROPATHY 6 0.0001
960 DEVICE BREAKAGE 6 0.0001
961 PSORIASIS 19 0.0001
962 ANAPHYLACTIC REACTION 8 0.0001
963 WITHDRAWAL SYNDROME 6 0.0001
964 CONVULSION 8 0.0001
965 AGGRESSION 7 0.0001
966 BREAST CANCER 13 0.0001
967 BLADDER CANCER 8 0.0001
968 PANCREATITIS 7 0.0001
969 PRODUCT USE IN UNAPPROVED INDICATION 32 0.0001
970 DEVICE MALFUNCTION 9 0.0001
971 DRUG-INDUCED LIVER INJURY 4 0.0001
972 MOOD SWINGS 4 0.0001
973 INJECTION SITE HAEMORRHAGE 10 0.0001
974 MOVEMENT DISORDER 4 0.0001
975 INFUSION RELATED REACTION 7 0.0001
976 INJECTION SITE SWELLING 8 0.0001
977 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
978 TOXICITY TO VARIOUS AGENTS 16 0.0001
979 INJECTION SITE PAIN 29 0.0001
980 DEVICE DISLOCATION 4 0.0001
981 INJECTION SITE PRURITUS 6 0.0001
982 SUICIDAL IDEATION 8 0.0001
983 DEVICE ISSUE 7 0.0001
984 ILLNESS 8 0.0001
985 INJECTION SITE BRUISING 6 0.0001
986 INJECTION SITE ERYTHEMA 8 0.0001
987 DEVICE DIFFICULT TO USE 4 0.0001
988 MATERNAL EXPOSURE DURING PREGNANCY 5 0.0001